A distinct innate immune signature marks progression from mild to severe COVID-19
S. Chevrier, Y. Zurbuchen, C. Cervia…·B. Bodenmiller
The paper identifies an innate immune signature associated with progression from mild to severe COVID-19 using mass cytometry and proteomics.